Did you know? USP <665> compliance is expected by 2026

Published: 18-Jul-2024
Manufacturing Research & Development

Ensuring compliance and safety in single-use manufacturing

This chapter provides crucial guidance on analytical testing of single-use systems (SUS) to mitigate risks associated with extractables and leachables. With the deadline fast approaching, it's essential for drug developers to start preparing now.

Download our white paper with risk assessments, and practical steps for seamless compliance.

https://eu1.hubs.ly/H0bc2K80

  • Companies:
  • Solvias
See more

You may also like

Manufacturing

Solvias to build Biologics and Cell & Gene Therapy testing centre in Research Triangle Park

Read more
Global provider continues to expand analytical service capabilities for life science companies developing advanced treatments for cancer and rare diseases

Trending Articles

  1. Sanofi invests €40m into biopharmaceutical manufacturing at its Lyon Gerland site The pharma giant has expanded its French monoclonal antibody production capabilities, while also dedicating €25m to the development of a second-gen polyclonal antibody
  2. BioPharmaSpec expands its biopharma discovery and preclinical capabilities with three new facilities The contract research organisation (CRO) has expanded its European presence with three facilities, which are catered for biopharmaceutical drug discovery and preclinical characterisation
  3. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  4. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company
  5. Ardena's Oss nanomedicine facility gains full GMP approval from the Dutch Healthcare Authority The pharmaceutical manufacturing facility can produce advanced nanoparticle drug delivery systems, including lipid-based, polymeric and metal oxide nanoparticles

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Manufacturing

Solvias to build Biologics and Cell & Gene Therapy testing centre in Research Triangle Park

Global provider continues to expand analytical service capabilities for life science companies developing advanced treatments for cancer and rare diseases
Manufacturing

Solvias to perform release testing on world’s first CRISPR-based gene-editing therapy

Global provider signs long-term agreement with Vertex Pharmaceuticals for CASGEVY (trademarked)
Manufacturing

Solvias acquires Cergentis to boost biologics testing capabilities

The pharma testing company has made the acquisition to supports the increasing number of global pharmaceutical, biotech, and contract development and manufacturing organisations developing genetically engineered therapies
Manufacturing

Hovione and Solvias announce a collaboration to improve drug solubility

Combines the strengths of each company
Manufacturing

Samsung Biologics bags $668 manufacturing deal with European pharmaceutical company

The CDMO will be responsible for the manufacture of the client's biopharmaceuticals until December 2031
Manufacturing

CDMO GBI Biomanufacturing expands US drug product services with aseptic fill/finish capabilities

Its Florida site will now be able to support biopharma clients from clinical trials to commercialisation with a dual manual/automated fill/finish approach
Manufacturing

Sartorius Stedim Biotech supports bioprocess development with new Innovation Centre

The Massachusetts, US-based Centre for Bioprocess Innovation is a collaborative space designed to develop and optimise biomanufacturing processes
Subscribe now